Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy

Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy

Background. No studies have evaluated the impact of multiple generic immunosuppression medications on transplant coordinators (TCs) and patients. Methods. A cross-sectional, multicenter online survey of TCs managing transplant recipients' outpatient immunosuppression was undertaken to assess T...

Full description

Bibliographic Details
Main Authors:	K. Parker, E. A. Zagadailov, A. S. Bruno, A. M. Wiland
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	Journal of Transplantation
Online Access:	http://dx.doi.org/10.1155/2013/897434

Similar Items

Late-onset posttransplant lymphoproliferative disease in a male kidney transplant patient on minimal triple immunosuppressive therapy: Diagnosis and management
by: Sneha Haridas Anupama, et al.
Published: (2019-01-01)

Outcome of Rapamycin Therapy for PostTransplant- Lymphoproliferative Disorder after Kidney Transplantation: Case Series
by: Farzaneh Ashrafi, et al.
Published: (2015-03-01)

Belatacept for Maintenance Immunosuppression in Lung Transplantation
by: Christine Hui PharmD, et al.
Published: (2014-06-01)

Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality
by: Rivinius R, et al.
Published: (2017-10-01)

THE INDIVIDUAL TAILORING OF IMMUNOSUPPRESSIVE THERAPY AFTER HEART TRANSPLANTATION
by: N. N. Koloskova, et al.
Published: (2018-04-01)

Immunosuppressive Therapy Protocols in Kidney Transplantation in Adults
by: Jasenko Karamehić, et al.
Published: (2006-08-01)

Is it Ethical to Prescribe Generic Immunosuppressive Drugs to Renal Transplant Patients?
by: Julie Allard, et al.
Published: (2014-09-01)

Sixteen-Year Cohort of Liver Transplantation in the National Health System in Brazil: Analysis of Immunosuppression Maintenance Therapies
by: Guilherme Fagundes Nascimento, et al.
Published: (2020-10-01)

Safety of Immunosuppressive Drugs Used as Maintenance Therapy in Kidney Transplantation: A Systematic Review and Meta-Analysis
by: Celline Cardoso Almeida, et al.
Published: (2013-09-01)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
by: Isabel P. Neuringer
Published: (2013-01-01)

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
by: Andrea Bacigalupo, et al.
Published: (2016-01-01)

The basic principles of immunosuppressive therapy after kidney transplantation
by: D. N. Suslov
Published: (2018-03-01)

Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy
by: Enrico Ammirati, et al.
Published: (2020-08-01)

Modulation of maintenance immunosuppression during infection in renal transplant recipients
by: M Edwin Fernando, et al.
Published: (2018-01-01)

Use of hyperbaric oxygenation in the combination therapy of posttransplant kidney patients in the early postoperative period
by: M. V. Romasenko, et al.
Published: (2018-08-01)

Surveillance of polyomavirus BK in relation to immunosuppressive therapy in kidney transplantation
by: Cristina Costa, et al.
Published: (2012-03-01)

SIGNIFICANCE OF THERAPY MONITORING OF IMMUNOSUPPRESSIVE MEDICINES IN RENAL TRANSPLANTATION PATIENTS
by: Vidojko Đorđević, et al.
Published: (2009-04-01)

Adherence to immunosuppressive therapy following liver transplantation: an integrative review
by: Ramon Antônio Oliveira, et al.

Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis
by: Mustafa Nazzal, MD, et al.
Published: (2018-07-01)

COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survival
by: Rivinius R, et al.
Published: (2018-09-01)

A case of rhabdomyolysis after atorvastatin therapy of a liver transplant recipient receiving immunosuppressive therapy with cyclosporine
by: A. V. Shabunin, et al.
Published: (2021-06-01)

Posttransplant Lymphoproliferative Disorders
by: Hazem A. H. Ibrahim, et al.
Published: (2012-01-01)

Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
by: Martin Mynarek, et al.
Published: (2013-01-01)

Aggressive angiomyxoma of transplanted kidney mimicking posttransplant lymphoproliferative disorder
by: Ujjwal Gorsi, et al.
Published: (2017-01-01)

The choice of immunosuppressive therapy depending on the level of anti-HLA antibodies in kidney transplantation
by: N. V. Borovkova, et al.
Published: (2018-03-01)

Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update
by: Dilan A. Patel, et al.
Published: (2020-06-01)

Belatacept as salvage maintenance immunosuppression in a liver transplant recipient
by: Kyle Lang, et al.
Published: (2020-12-01)

Abstract 42: Trends of Maintenance Immunosuppression in Hand and Facial Transplantation
by: Amit K. Manjunath, BS, et al.
Published: (2018-04-01)

Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient
by: Anita Abhyankar, et al.
Published: (2013-12-01)

Current biochemical monitoring and risk management of immunosuppressive therapy after transplantation
by: Catić-Đorđević Aleksandra, et al.
Published: (2017-01-01)

Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation
by: Jesus Ruiz, et al.
Published: (2015-08-01)

Discontinuation of immunosuppressive therapy after liver transplantation: an analysis of one case
by: LYU Guoyue
Published: (2013-09-01)

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
by: Liu FC, et al.
Published: (2017-08-01)

An assessment of adherence to immunosuppressive therapy and impact factors in renal transplant recipients
by: Ching-Yao Cheng, et al.
Published: (2011)

Pulmonary Function Testing Pre–heart Transplant Predicts Posttransplant Survival
by: Scott W. Lundgren, DO, et al.
Published: (2021-10-01)

Posttransplant Cellular Immune Reactivity against Donor Antigen Correlates with Clinical Islet Transplantation Outcome: Towards a Better Posttransplant Monitoring
by: Stéphanie Lacotte, et al.
Published: (2012-11-01)

Long-term outcomes of kidney transplantation in terms of different variants of maintenance immunosuppression
by: N. A. Tomilina, et al.
Published: (2016-02-01)

Effectiveness of Maintenance Immunosuppression Therapies in a Matched-Pair Analysis Cohort of 16 Years of Renal Transplant in the Brazilian National Health System
by: Rosângela Maria Gomes, et al.
Published: (2020-03-01)

Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen.
by: Gianluigi Zaza, et al.
Published: (2017-01-01)

The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia
by: A A Ganapiyev, et al.
Published: (2010-07-01)